Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer

被引:0
|
作者
Younji Kim
Anne Marie McCarthy
Mirar Bristol
Katrina Armstrong
机构
[1] Massachusetts General Hospital,
[2] Harvard Medical School,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Contralateral prophylactic mastectomy use has increased over the past decades among women with early-stage breast cancer. Racial differences in contralateral prophylactic mastectomy use are well described, but with unclear causes. This study examined contralateral prophylactic mastectomy use among black and white women and the contribution of differences in perceived risk to differences in use. We surveyed women diagnosed with early-stage unilateral breast cancer between ages 41–64 in Pennsylvania and Florida between 2007–2009 to collect data on breast cancer treatment, family history, education, income, insurance, and perceived risk. Clinical factors—age,stage at diagnosis, receptor status—were obtained from cancer registries. The relationships between patient factors and contralateral prophylactic mastectomy were assessed using logistic regression. The interaction between race and contralateral prophylactic mastectomy on the perceived risk of second breast cancers was tested using linear regression. Of 2182 study participants, 18% of whites underwent contralateral prophylactic mastectomy compared with 10% of blacks (p < 0.001). The racial difference remained after adjustment for clinical factors and family history (odds ratio = 2.32, 95% confidence interval 1.76–3.06, p < 0.001). The association between contralateral prophylactic mastectomy and a reduction in the perceived risk of second breast cancers was significantly smaller for blacks than whites. Blacks were less likely than whites to undergo contralateral prophylactic mastectomy even after adjustment for clinical factors. This racial difference in use may relate to the smaller impact of contralateral prophylactic mastectomy on the perceived risk of second breast cancers among blacks than among whites. Future research is needed to understand the overall impact of perceived risk on decisions about contralateral prophylactic mastectomy and how that may explain racial differences in use.
引用
收藏
相关论文
共 50 条
  • [31] Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer
    Terkelsen, Thorkild
    Ronning, Hanne
    Skytte, Anne-Bine
    ACTA ONCOLOGICA, 2020, 59 (01) : 60 - 65
  • [32] Perceptions, Knowledge and Satisfaction with Contralateral Prophylactic Mastectomy among Young Women with Breast Cancer.
    Tracy, M. S.
    Meyer, M. E.
    Sepucha, K.
    Gelber, S.
    Hirshfield-Bartek, J.
    Troyan, S.
    Morrow, M.
    Schapira, L.
    Come, S.
    Winer, E.
    Partridge, A. H.
    CANCER RESEARCH, 2011, 71
  • [33] Factors associated with contralateral prophylactic mastectomy in young women with breast cancer
    Rosenberg, S. M.
    Sepucha, K.
    Ruddy, K. J.
    Tamimi, R. M.
    Gelber, S.
    Meyer, M. E.
    Schapira, L.
    Come, S. E.
    Borges, V. F.
    Winer, E. P.
    Partridge, A. H.
    CANCER RESEARCH, 2013, 73
  • [34] Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
    Marilyn L. Kwan
    Jiaxiao M. Shi
    Laurel A. Habel
    Jun Song
    Joanie W-L Chung
    Chantal C. Avila
    Joanne E. Schottinger
    T. Craig Cheetham
    Suzanne W. Fletcher
    Reina Haque
    Breast Cancer Research and Treatment, 2016, 156 : 379 - 389
  • [35] Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
    Kwan, Marilyn L.
    Shi, Jiaxiao M.
    Habel, Laurel A.
    Song, Jun
    Chung, Joanie W-L
    Avila, Chantal C.
    Schottinger, Joanne E.
    Cheetham, T. Craig
    Fletcher, Suzanne W.
    Haque, Reina
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (02) : 379 - 389
  • [36] Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
    Kristi D. Graves
    Beth N. Peshkin
    Chanita H. Halbert
    Tiffani A. DeMarco
    Claudine Isaacs
    Marc D. Schwartz
    Breast Cancer Research and Treatment, 2007, 104 : 321 - 329
  • [37] Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
    Graves, Kristi D.
    Peshkin, Beth N.
    Halbert, Chanita H.
    DeMarco, Tiffani A.
    Isaacs, Claudine
    Schwartz, Marc D.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 104 (03) : 321 - 329
  • [38] Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer
    Chavez-MacGregor, Mariana
    Lei, Xiudong
    Malinowski, Catalina
    Zhao, Hui
    Shih, Ya-Chen
    Giordano, Sharon H.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (06): : 644 - 651
  • [39] Contralateral Prophylactic Mastectomy in Patients with Breast Cancer
    Noditi, Aniela
    Caragheorghe, George
    Stoleru, Smaranda
    Blidaru, Alexandru
    Bordea, Cristian Ioan
    CHIRURGIA, 2021, 116 (02) : S73 - S83
  • [40] Contralateral prophylactic mastectomy decision-making in the population-based iCanCare study of early-stage breast cancer patients.
    Jagsi, Reshma
    Hawley, Sarah T.
    Griffith, Kent A.
    Janz, Nancy K.
    Kurian, Allison W.
    Ward, Kevin C.
    Hamilton, Ann S.
    Katz, Steven J.
    Morrow, Monica
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)